QoL-Comparison Between Trabectedin/PLD and Pt-based Therapy in Patients With Pt-sensitive Recurrent Ovarian Cancer

NCT03164980 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
89
Enrollment
OTHER
Sponsor class

Stopped A total of 204 patients were planned to be randomized. Due to slow recruitment of the trial, the recruitment was prematurely terminated after randomization of the 89th patient.

Conditions

Interventions

Sponsor

North Eastern German Society of Gynaecological Oncology

Collaborators